SEC Form 4 · accession 0001179110-16-025597
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G. Savage
Director
Period of report
May 24, 2016
Accepted (ET)
May 26, 2016 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 24, 2016 | M | 10,000 | $18.60 | A | 37,720 | D | |
| Common StockF1,F2 | May 24, 2016 | S | 10,000 | $36.95 | D | 27,720 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F4,F3 | $18.60 | May 24, 2016 | M | 10,000 | D | — | May 25, 2016 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b-5 program adopted by Mr. Savage.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $36.51 to a high of $37.17 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This option vested in twelve equal installments beginning on June 25, 2006.
- F4Not applicable.